Transplant Testing
HLA Pretransplant Workup Panel 2 Test
The HLA Pretransplant Workup Panel 2 Test assesses compatibility between organ donors and recipients to improve transplant success rates. This test is a key part of the evaluation process before organ transplantation.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Blood sample (typically collected in EDTA tubes). Confirm specific requirements with the laboratory before booking.
- Results
- Confirm with the laboratory before booking.
- Preparation
- No special preparation is typically required for this blood test. Confirm with the laboratory before booking.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the HLA Pretransplant Workup Panel 2 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients awaiting organ transplantation
- ✓Potential living organ donors
- ✓Evaluation of previous transplant failure
- ✓Assessment of risk for transplant rejection
- ✓Guiding immunosuppressive therapy selection
In plain language
What this test helps you understand
This test measures the specific HLA antigens present in the donor and recipient's blood. By identifying these antigens, healthcare providers can assess the likelihood of transplant rejection and tailor immunosuppressive therapies accordingly. The test employs advanced methodologies including Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP - Luminex, and Flow Cytometry to ensure accurate results.
Individuals who are considering organ transplantation, either as a recipient or a donor, should undergo the HLA Pretransplant Workup Panel 2 Test. This includes individuals with chronic kidney disease requiring dialysis or transplantation, end-stage organ failure, previous transplant failures, or a family history of organ transplant complications. Risk factors such as autoimmune diseases or prior organ transplants also warrant consideration for this test.
Taking this test ensures compatibility between donor and recipient, reducing the risk of rejection. It guides the selection of appropriate immunosuppressive therapy post-transplant, offers peace of mind for both donors and recipients regarding transplant success, and facilitates better planning and management of transplant procedures.
Results from the HLA Pretransplant Workup Panel 2 Test will indicate the compatibility level between the donor and recipient. A higher compatibility score suggests a lower risk of rejection, while lower scores require careful consideration of immunosuppressive strategies. It is essential to consult with your transplant team to interpret these results accurately.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Chimerism Split Cell Analysis T Cell CD3 Test
Monitors post-transplant recovery by measuring the proportion of donor and recipient T cells (CD3 positive) in the blood or bone marrow. Essential for assessing graft acceptance or rejection after hematopoietic stem cell transplantation.
Learn more →HLA ABC Class 1 Typing Test
The HLA ABC Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation.
Learn more →HLA AB Class 1 Typing Test
The HLA AB Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful kidney, liver, or heart transplants. This test identifies specific antigens to minimize organ rejection risk.
Learn more →HLA DP Typing Test
The HLA DP Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation. It assesses specific human leukocyte antigens (HLA) to minimize rejection risk.
Learn more →